nodes	percent_of_prediction	percent_of_DWPC	metapath
Phenytoin—SLCO1C1—Methotrexate—lymphatic system cancer	0.138	0.196	CbGbCtD
Phenytoin—CYP3A5—Teniposide—lymphatic system cancer	0.068	0.0963	CbGbCtD
Phenytoin—ABCC2—Vincristine—lymphatic system cancer	0.0654	0.0925	CbGbCtD
Phenytoin—CYP2C19—Teniposide—lymphatic system cancer	0.0549	0.0777	CbGbCtD
Phenytoin—CYP2C9—Teniposide—lymphatic system cancer	0.0456	0.0646	CbGbCtD
Phenytoin—CYP3A7—Vincristine—lymphatic system cancer	0.0436	0.0618	CbGbCtD
Phenytoin—CYP3A7-CYP3A51P—Vincristine—lymphatic system cancer	0.0436	0.0618	CbGbCtD
Phenytoin—ABCC2—Methotrexate—lymphatic system cancer	0.0396	0.056	CbGbCtD
Phenytoin—CYP3A5—Vincristine—lymphatic system cancer	0.0327	0.0463	CbGbCtD
Phenytoin—ABCB1—Mitoxantrone—lymphatic system cancer	0.031	0.0438	CbGbCtD
Phenytoin—CYP3A4—Cytarabine—lymphatic system cancer	0.0269	0.0381	CbGbCtD
Phenytoin—CYP3A4—Teniposide—lymphatic system cancer	0.0265	0.0375	CbGbCtD
Phenytoin—ALB—Methotrexate—lymphatic system cancer	0.0247	0.0349	CbGbCtD
Phenytoin—ABCB1—Vincristine—lymphatic system cancer	0.0213	0.0302	CbGbCtD
Phenytoin—CYP3A4—Mitoxantrone—lymphatic system cancer	0.0186	0.0263	CbGbCtD
Phenytoin—ABCB1—Methotrexate—lymphatic system cancer	0.0129	0.0183	CbGbCtD
Phenytoin—CYP3A4—Vincristine—lymphatic system cancer	0.0128	0.0181	CbGbCtD
Phenytoin—Fatigue—Fludarabine—lymphatic system cancer	0.000425	0.00145	CcSEcCtD
Phenytoin—Inflammation—Methotrexate—lymphatic system cancer	0.000422	0.00144	CcSEcCtD
Phenytoin—Hypoaesthesia—Vincristine—lymphatic system cancer	0.000421	0.00144	CcSEcCtD
Phenytoin—Constipation—Fludarabine—lymphatic system cancer	0.000421	0.00144	CcSEcCtD
Phenytoin—Bradycardia—Mitoxantrone—lymphatic system cancer	0.00042	0.00143	CcSEcCtD
Phenytoin—Connective tissue disorder—Vincristine—lymphatic system cancer	0.000416	0.00142	CcSEcCtD
Phenytoin—Haemoglobin—Mitoxantrone—lymphatic system cancer	0.000414	0.00141	CcSEcCtD
Phenytoin—Rhinitis—Mitoxantrone—lymphatic system cancer	0.000413	0.00141	CcSEcCtD
Phenytoin—Hypersensitivity—Teniposide—lymphatic system cancer	0.000413	0.00141	CcSEcCtD
Phenytoin—Haemorrhage—Mitoxantrone—lymphatic system cancer	0.000412	0.00141	CcSEcCtD
Phenytoin—Ill-defined disorder—Bleomycin—lymphatic system cancer	0.00041	0.0014	CcSEcCtD
Phenytoin—Pharyngitis—Mitoxantrone—lymphatic system cancer	0.000409	0.00139	CcSEcCtD
Phenytoin—Pulmonary embolism—Methotrexate—lymphatic system cancer	0.000409	0.00139	CcSEcCtD
Phenytoin—Vaginal inflammation—Methotrexate—lymphatic system cancer	0.000409	0.00139	CcSEcCtD
Phenytoin—Anaemia—Bleomycin—lymphatic system cancer	0.000409	0.00139	CcSEcCtD
Phenytoin—Feeling abnormal—Fludarabine—lymphatic system cancer	0.000406	0.00138	CcSEcCtD
Phenytoin—Asthenia—Teniposide—lymphatic system cancer	0.000402	0.00137	CcSEcCtD
Phenytoin—Malaise—Bleomycin—lymphatic system cancer	0.000399	0.00136	CcSEcCtD
Phenytoin—Pruritus—Teniposide—lymphatic system cancer	0.000396	0.00135	CcSEcCtD
Phenytoin—Leukopenia—Bleomycin—lymphatic system cancer	0.000396	0.00135	CcSEcCtD
Phenytoin—Depressed level of consciousness—Methotrexate—lymphatic system cancer	0.000395	0.00135	CcSEcCtD
Phenytoin—Body temperature increased—Fludarabine—lymphatic system cancer	0.000389	0.00133	CcSEcCtD
Phenytoin—Vaginal infection—Methotrexate—lymphatic system cancer	0.000386	0.00132	CcSEcCtD
Phenytoin—Cough—Bleomycin—lymphatic system cancer	0.000386	0.00132	CcSEcCtD
Phenytoin—Diarrhoea—Teniposide—lymphatic system cancer	0.000383	0.00131	CcSEcCtD
Phenytoin—Chest pain—Bleomycin—lymphatic system cancer	0.000377	0.00128	CcSEcCtD
Phenytoin—Myalgia—Bleomycin—lymphatic system cancer	0.000377	0.00128	CcSEcCtD
Phenytoin—Coma—Methotrexate—lymphatic system cancer	0.000374	0.00127	CcSEcCtD
Phenytoin—Back pain—Carmustine—lymphatic system cancer	0.000374	0.00127	CcSEcCtD
Phenytoin—Discomfort—Bleomycin—lymphatic system cancer	0.000372	0.00127	CcSEcCtD
Phenytoin—Chills—Mitoxantrone—lymphatic system cancer	0.00037	0.00126	CcSEcCtD
Phenytoin—Urine output increased—Methotrexate—lymphatic system cancer	0.00037	0.00126	CcSEcCtD
Phenytoin—Ecchymosis—Methotrexate—lymphatic system cancer	0.00037	0.00126	CcSEcCtD
Phenytoin—Gynaecomastia—Methotrexate—lymphatic system cancer	0.000366	0.00125	CcSEcCtD
Phenytoin—Confusional state—Bleomycin—lymphatic system cancer	0.000364	0.00124	CcSEcCtD
Phenytoin—Hypersensitivity—Fludarabine—lymphatic system cancer	0.000363	0.00124	CcSEcCtD
Phenytoin—Tremor—Carmustine—lymphatic system cancer	0.000362	0.00123	CcSEcCtD
Phenytoin—Anaphylactic shock—Bleomycin—lymphatic system cancer	0.000361	0.00123	CcSEcCtD
Phenytoin—Infection—Bleomycin—lymphatic system cancer	0.000359	0.00122	CcSEcCtD
Phenytoin—Anaemia—Carmustine—lymphatic system cancer	0.000357	0.00122	CcSEcCtD
Phenytoin—Back pain—Vincristine—lymphatic system cancer	0.000357	0.00122	CcSEcCtD
Phenytoin—Vomiting—Teniposide—lymphatic system cancer	0.000356	0.00121	CcSEcCtD
Phenytoin—Sepsis—Methotrexate—lymphatic system cancer	0.000355	0.00121	CcSEcCtD
Phenytoin—Agitation—Carmustine—lymphatic system cancer	0.000355	0.00121	CcSEcCtD
Phenytoin—Thrombocytopenia—Bleomycin—lymphatic system cancer	0.000354	0.0012	CcSEcCtD
Phenytoin—Asthenia—Fludarabine—lymphatic system cancer	0.000353	0.0012	CcSEcCtD
Phenytoin—Rash—Teniposide—lymphatic system cancer	0.000353	0.0012	CcSEcCtD
Phenytoin—Dermatitis—Teniposide—lymphatic system cancer	0.000353	0.0012	CcSEcCtD
Phenytoin—Dysgeusia—Mitoxantrone—lymphatic system cancer	0.000352	0.0012	CcSEcCtD
Phenytoin—Headache—Teniposide—lymphatic system cancer	0.000351	0.0012	CcSEcCtD
Phenytoin—Pruritus—Fludarabine—lymphatic system cancer	0.000348	0.00119	CcSEcCtD
Phenytoin—Lymphadenopathy—Methotrexate—lymphatic system cancer	0.000348	0.00119	CcSEcCtD
Phenytoin—Back pain—Mitoxantrone—lymphatic system cancer	0.000347	0.00118	CcSEcCtD
Phenytoin—Leukopenia—Carmustine—lymphatic system cancer	0.000346	0.00118	CcSEcCtD
Phenytoin—Anorexia—Bleomycin—lymphatic system cancer	0.000344	0.00117	CcSEcCtD
Phenytoin—Thrombophlebitis—Methotrexate—lymphatic system cancer	0.000343	0.00117	CcSEcCtD
Phenytoin—Anaemia—Vincristine—lymphatic system cancer	0.000341	0.00116	CcSEcCtD
Phenytoin—Agitation—Vincristine—lymphatic system cancer	0.000339	0.00115	CcSEcCtD
Phenytoin—Polyuria—Methotrexate—lymphatic system cancer	0.000338	0.00115	CcSEcCtD
Phenytoin—Hypotension—Bleomycin—lymphatic system cancer	0.000337	0.00115	CcSEcCtD
Phenytoin—Diarrhoea—Fludarabine—lymphatic system cancer	0.000337	0.00115	CcSEcCtD
Phenytoin—Convulsion—Carmustine—lymphatic system cancer	0.000335	0.00114	CcSEcCtD
Phenytoin—Hypertension—Carmustine—lymphatic system cancer	0.000333	0.00114	CcSEcCtD
Phenytoin—Ill-defined disorder—Mitoxantrone—lymphatic system cancer	0.000333	0.00114	CcSEcCtD
Phenytoin—Nausea—Teniposide—lymphatic system cancer	0.000333	0.00113	CcSEcCtD
Phenytoin—Anaemia—Mitoxantrone—lymphatic system cancer	0.000332	0.00113	CcSEcCtD
Phenytoin—Vertigo—Vincristine—lymphatic system cancer	0.000331	0.00113	CcSEcCtD
Phenytoin—Leukopenia—Vincristine—lymphatic system cancer	0.00033	0.00112	CcSEcCtD
Phenytoin—Musculoskeletal discomfort—Bleomycin—lymphatic system cancer	0.000329	0.00112	CcSEcCtD
Phenytoin—Myalgia—Carmustine—lymphatic system cancer	0.000329	0.00112	CcSEcCtD
Phenytoin—Chest pain—Carmustine—lymphatic system cancer	0.000329	0.00112	CcSEcCtD
Phenytoin—Paraesthesia—Bleomycin—lymphatic system cancer	0.000324	0.0011	CcSEcCtD
Phenytoin—Malaise—Mitoxantrone—lymphatic system cancer	0.000324	0.0011	CcSEcCtD
Phenytoin—Dyspnoea—Bleomycin—lymphatic system cancer	0.000322	0.0011	CcSEcCtD
Phenytoin—Leukopenia—Mitoxantrone—lymphatic system cancer	0.000321	0.0011	CcSEcCtD
Phenytoin—Convulsion—Vincristine—lymphatic system cancer	0.000319	0.00109	CcSEcCtD
Phenytoin—Hypertension—Vincristine—lymphatic system cancer	0.000318	0.00108	CcSEcCtD
Phenytoin—Confusional state—Carmustine—lymphatic system cancer	0.000318	0.00108	CcSEcCtD
Phenytoin—Decreased appetite—Bleomycin—lymphatic system cancer	0.000314	0.00107	CcSEcCtD
Phenytoin—Myalgia—Vincristine—lymphatic system cancer	0.000314	0.00107	CcSEcCtD
Phenytoin—Cough—Mitoxantrone—lymphatic system cancer	0.000313	0.00107	CcSEcCtD
Phenytoin—Infection—Carmustine—lymphatic system cancer	0.000313	0.00107	CcSEcCtD
Phenytoin—Vomiting—Fludarabine—lymphatic system cancer	0.000313	0.00107	CcSEcCtD
Phenytoin—Convulsion—Mitoxantrone—lymphatic system cancer	0.000311	0.00106	CcSEcCtD
Phenytoin—Rash—Fludarabine—lymphatic system cancer	0.00031	0.00106	CcSEcCtD
Phenytoin—Dermatitis—Fludarabine—lymphatic system cancer	0.00031	0.00106	CcSEcCtD
Phenytoin—Hypertension—Mitoxantrone—lymphatic system cancer	0.00031	0.00106	CcSEcCtD
Phenytoin—Thrombocytopenia—Carmustine—lymphatic system cancer	0.000309	0.00105	CcSEcCtD
Phenytoin—Headache—Fludarabine—lymphatic system cancer	0.000308	0.00105	CcSEcCtD
Phenytoin—Tachycardia—Carmustine—lymphatic system cancer	0.000308	0.00105	CcSEcCtD
Phenytoin—Anaphylactoid reaction—Methotrexate—lymphatic system cancer	0.000307	0.00105	CcSEcCtD
Phenytoin—Myalgia—Mitoxantrone—lymphatic system cancer	0.000306	0.00104	CcSEcCtD
Phenytoin—Chest pain—Mitoxantrone—lymphatic system cancer	0.000306	0.00104	CcSEcCtD
Phenytoin—Arthralgia—Mitoxantrone—lymphatic system cancer	0.000306	0.00104	CcSEcCtD
Phenytoin—Discomfort—Mitoxantrone—lymphatic system cancer	0.000302	0.00103	CcSEcCtD
Phenytoin—Anaphylactic shock—Vincristine—lymphatic system cancer	0.000301	0.00103	CcSEcCtD
Phenytoin—Anorexia—Carmustine—lymphatic system cancer	0.0003	0.00102	CcSEcCtD
Phenytoin—Infection—Vincristine—lymphatic system cancer	0.000299	0.00102	CcSEcCtD
Phenytoin—Feeling abnormal—Bleomycin—lymphatic system cancer	0.000298	0.00101	CcSEcCtD
Phenytoin—Osteoarthritis—Methotrexate—lymphatic system cancer	0.000297	0.00101	CcSEcCtD
Phenytoin—Confusional state—Mitoxantrone—lymphatic system cancer	0.000295	0.00101	CcSEcCtD
Phenytoin—Nervous system disorder—Vincristine—lymphatic system cancer	0.000295	0.00101	CcSEcCtD
Phenytoin—Thrombocytopenia—Vincristine—lymphatic system cancer	0.000295	0.001	CcSEcCtD
Phenytoin—Hypotension—Carmustine—lymphatic system cancer	0.000294	0.001	CcSEcCtD
Phenytoin—Anaphylactic shock—Mitoxantrone—lymphatic system cancer	0.000293	0.000999	CcSEcCtD
Phenytoin—Nausea—Fludarabine—lymphatic system cancer	0.000293	0.000997	CcSEcCtD
Phenytoin—Infection—Mitoxantrone—lymphatic system cancer	0.000291	0.000992	CcSEcCtD
Phenytoin—Hyperhidrosis—Vincristine—lymphatic system cancer	0.000291	0.000991	CcSEcCtD
Phenytoin—Shock—Mitoxantrone—lymphatic system cancer	0.000288	0.000982	CcSEcCtD
Phenytoin—Musculoskeletal discomfort—Carmustine—lymphatic system cancer	0.000287	0.000979	CcSEcCtD
Phenytoin—Thrombocytopenia—Mitoxantrone—lymphatic system cancer	0.000287	0.000978	CcSEcCtD
Phenytoin—Urticaria—Bleomycin—lymphatic system cancer	0.000287	0.000977	CcSEcCtD
Phenytoin—Anorexia—Vincristine—lymphatic system cancer	0.000287	0.000977	CcSEcCtD
Phenytoin—Tachycardia—Mitoxantrone—lymphatic system cancer	0.000286	0.000975	CcSEcCtD
Phenytoin—Body temperature increased—Bleomycin—lymphatic system cancer	0.000285	0.000973	CcSEcCtD
Phenytoin—Insomnia—Carmustine—lymphatic system cancer	0.000285	0.000971	CcSEcCtD
Phenytoin—Irritability—Methotrexate—lymphatic system cancer	0.000283	0.000966	CcSEcCtD
Phenytoin—Hyperhidrosis—Mitoxantrone—lymphatic system cancer	0.000283	0.000965	CcSEcCtD
Phenytoin—Paraesthesia—Carmustine—lymphatic system cancer	0.000283	0.000964	CcSEcCtD
Phenytoin—Mood swings—Methotrexate—lymphatic system cancer	0.000281	0.000959	CcSEcCtD
Phenytoin—Hypotension—Vincristine—lymphatic system cancer	0.000281	0.000958	CcSEcCtD
Phenytoin—Dyspnoea—Carmustine—lymphatic system cancer	0.000281	0.000958	CcSEcCtD
Phenytoin—Somnolence—Carmustine—lymphatic system cancer	0.00028	0.000955	CcSEcCtD
Phenytoin—Anorexia—Mitoxantrone—lymphatic system cancer	0.000279	0.000952	CcSEcCtD
Phenytoin—Ataxia—Methotrexate—lymphatic system cancer	0.000279	0.000952	CcSEcCtD
Phenytoin—Liver function test abnormal—Methotrexate—lymphatic system cancer	0.000274	0.000934	CcSEcCtD
Phenytoin—Musculoskeletal discomfort—Vincristine—lymphatic system cancer	0.000274	0.000934	CcSEcCtD
Phenytoin—Decreased appetite—Carmustine—lymphatic system cancer	0.000274	0.000934	CcSEcCtD
Phenytoin—Hypotension—Mitoxantrone—lymphatic system cancer	0.000274	0.000933	CcSEcCtD
Phenytoin—Insomnia—Vincristine—lymphatic system cancer	0.000272	0.000927	CcSEcCtD
Phenytoin—Gastrointestinal disorder—Carmustine—lymphatic system cancer	0.000272	0.000927	CcSEcCtD
Phenytoin—Paraesthesia—Vincristine—lymphatic system cancer	0.00027	0.000921	CcSEcCtD
Phenytoin—Constipation—Carmustine—lymphatic system cancer	0.00027	0.000918	CcSEcCtD
Phenytoin—Breast disorder—Methotrexate—lymphatic system cancer	0.000268	0.000915	CcSEcCtD
Phenytoin—Toxic epidermal necrolysis—Methotrexate—lymphatic system cancer	0.000267	0.000911	CcSEcCtD
Phenytoin—Musculoskeletal discomfort—Mitoxantrone—lymphatic system cancer	0.000267	0.00091	CcSEcCtD
Phenytoin—Hypersensitivity—Bleomycin—lymphatic system cancer	0.000266	0.000907	CcSEcCtD
Phenytoin—Paraesthesia—Mitoxantrone—lymphatic system cancer	0.000263	0.000897	CcSEcCtD
Phenytoin—Decreased appetite—Vincristine—lymphatic system cancer	0.000262	0.000891	CcSEcCtD
Phenytoin—Dyspnoea—Mitoxantrone—lymphatic system cancer	0.000261	0.00089	CcSEcCtD
Phenytoin—Somnolence—Mitoxantrone—lymphatic system cancer	0.00026	0.000888	CcSEcCtD
Phenytoin—Gastrointestinal disorder—Vincristine—lymphatic system cancer	0.00026	0.000885	CcSEcCtD
Phenytoin—Feeling abnormal—Carmustine—lymphatic system cancer	0.00026	0.000885	CcSEcCtD
Phenytoin—Fatigue—Vincristine—lymphatic system cancer	0.000259	0.000884	CcSEcCtD
Phenytoin—Asthenia—Bleomycin—lymphatic system cancer	0.000259	0.000883	CcSEcCtD
Phenytoin—Dyspepsia—Mitoxantrone—lymphatic system cancer	0.000258	0.000879	CcSEcCtD
Phenytoin—Constipation—Vincristine—lymphatic system cancer	0.000257	0.000877	CcSEcCtD
Phenytoin—Asthma—Methotrexate—lymphatic system cancer	0.000257	0.000875	CcSEcCtD
Phenytoin—Pruritus—Bleomycin—lymphatic system cancer	0.000255	0.000871	CcSEcCtD
Phenytoin—Decreased appetite—Mitoxantrone—lymphatic system cancer	0.000255	0.000868	CcSEcCtD
Phenytoin—Eosinophilia—Methotrexate—lymphatic system cancer	0.000254	0.000866	CcSEcCtD
Phenytoin—Fatigue—Mitoxantrone—lymphatic system cancer	0.000253	0.000861	CcSEcCtD
Phenytoin—Constipation—Mitoxantrone—lymphatic system cancer	0.000251	0.000854	CcSEcCtD
Phenytoin—Body temperature increased—Carmustine—lymphatic system cancer	0.000249	0.000849	CcSEcCtD
Phenytoin—Pancytopenia—Methotrexate—lymphatic system cancer	0.000244	0.000831	CcSEcCtD
Phenytoin—Feeling abnormal—Mitoxantrone—lymphatic system cancer	0.000241	0.000823	CcSEcCtD
Phenytoin—Dysuria—Methotrexate—lymphatic system cancer	0.00024	0.000818	CcSEcCtD
Phenytoin—Body temperature increased—Vincristine—lymphatic system cancer	0.000238	0.000811	CcSEcCtD
Phenytoin—Photosensitivity reaction—Methotrexate—lymphatic system cancer	0.000234	0.000799	CcSEcCtD
Phenytoin—Urticaria—Mitoxantrone—lymphatic system cancer	0.000233	0.000793	CcSEcCtD
Phenytoin—Hypersensitivity—Carmustine—lymphatic system cancer	0.000232	0.000791	CcSEcCtD
Phenytoin—Body temperature increased—Mitoxantrone—lymphatic system cancer	0.000232	0.000789	CcSEcCtD
Phenytoin—Pneumonia—Methotrexate—lymphatic system cancer	0.00023	0.000785	CcSEcCtD
Phenytoin—Vomiting—Bleomycin—lymphatic system cancer	0.00023	0.000782	CcSEcCtD
Phenytoin—Drowsiness—Methotrexate—lymphatic system cancer	0.000229	0.00078	CcSEcCtD
Phenytoin—Rash—Bleomycin—lymphatic system cancer	0.000228	0.000776	CcSEcCtD
Phenytoin—Dermatitis—Bleomycin—lymphatic system cancer	0.000227	0.000775	CcSEcCtD
Phenytoin—Stevens-Johnson syndrome—Methotrexate—lymphatic system cancer	0.000227	0.000773	CcSEcCtD
Phenytoin—Asthenia—Carmustine—lymphatic system cancer	0.000226	0.000771	CcSEcCtD
Phenytoin—Renal failure—Methotrexate—lymphatic system cancer	0.000225	0.000767	CcSEcCtD
Phenytoin—Conjunctivitis—Methotrexate—lymphatic system cancer	0.000222	0.000758	CcSEcCtD
Phenytoin—Hypersensitivity—Vincristine—lymphatic system cancer	0.000222	0.000755	CcSEcCtD
Phenytoin—Sweating—Methotrexate—lymphatic system cancer	0.000219	0.000748	CcSEcCtD
Phenytoin—Hepatobiliary disease—Methotrexate—lymphatic system cancer	0.000216	0.000738	CcSEcCtD
Phenytoin—Epistaxis—Methotrexate—lymphatic system cancer	0.000216	0.000736	CcSEcCtD
Phenytoin—Hypersensitivity—Mitoxantrone—lymphatic system cancer	0.000216	0.000736	CcSEcCtD
Phenytoin—Asthenia—Vincristine—lymphatic system cancer	0.000216	0.000736	CcSEcCtD
Phenytoin—Diarrhoea—Carmustine—lymphatic system cancer	0.000216	0.000735	CcSEcCtD
Phenytoin—Nausea—Bleomycin—lymphatic system cancer	0.000214	0.000731	CcSEcCtD
Phenytoin—Agranulocytosis—Methotrexate—lymphatic system cancer	0.000214	0.000728	CcSEcCtD
Phenytoin—Asthenia—Mitoxantrone—lymphatic system cancer	0.00021	0.000716	CcSEcCtD
Phenytoin—Dizziness—Carmustine—lymphatic system cancer	0.000208	0.00071	CcSEcCtD
Phenytoin—Haemoglobin—Methotrexate—lymphatic system cancer	0.000207	0.000704	CcSEcCtD
Phenytoin—Diarrhoea—Vincristine—lymphatic system cancer	0.000206	0.000702	CcSEcCtD
Phenytoin—Haemorrhage—Methotrexate—lymphatic system cancer	0.000205	0.0007	CcSEcCtD
Phenytoin—Pharyngitis—Methotrexate—lymphatic system cancer	0.000204	0.000695	CcSEcCtD
Phenytoin—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.0002	0.000683	CcSEcCtD
Phenytoin—Vomiting—Carmustine—lymphatic system cancer	0.0002	0.000683	CcSEcCtD
Phenytoin—Dizziness—Vincristine—lymphatic system cancer	0.000199	0.000678	CcSEcCtD
Phenytoin—Rash—Carmustine—lymphatic system cancer	0.000199	0.000677	CcSEcCtD
Phenytoin—Dermatitis—Carmustine—lymphatic system cancer	0.000199	0.000677	CcSEcCtD
Phenytoin—Headache—Carmustine—lymphatic system cancer	0.000197	0.000673	CcSEcCtD
Phenytoin—Erythema multiforme—Methotrexate—lymphatic system cancer	0.000194	0.000662	CcSEcCtD
Phenytoin—Tinnitus—Methotrexate—lymphatic system cancer	0.000192	0.000653	CcSEcCtD
Phenytoin—Vomiting—Vincristine—lymphatic system cancer	0.000191	0.000652	CcSEcCtD
Phenytoin—Rash—Vincristine—lymphatic system cancer	0.00019	0.000646	CcSEcCtD
Phenytoin—Dermatitis—Vincristine—lymphatic system cancer	0.00019	0.000646	CcSEcCtD
Phenytoin—Headache—Vincristine—lymphatic system cancer	0.000188	0.000642	CcSEcCtD
Phenytoin—Nausea—Carmustine—lymphatic system cancer	0.000187	0.000638	CcSEcCtD
Phenytoin—Vomiting—Mitoxantrone—lymphatic system cancer	0.000186	0.000635	CcSEcCtD
Phenytoin—Immune system disorder—Methotrexate—lymphatic system cancer	0.000186	0.000632	CcSEcCtD
Phenytoin—Rash—Mitoxantrone—lymphatic system cancer	0.000185	0.00063	CcSEcCtD
Phenytoin—Dermatitis—Mitoxantrone—lymphatic system cancer	0.000185	0.000629	CcSEcCtD
Phenytoin—Chills—Methotrexate—lymphatic system cancer	0.000184	0.000628	CcSEcCtD
Phenytoin—Headache—Mitoxantrone—lymphatic system cancer	0.000184	0.000626	CcSEcCtD
Phenytoin—Nausea—Vincristine—lymphatic system cancer	0.000179	0.000609	CcSEcCtD
Phenytoin—Dysgeusia—Methotrexate—lymphatic system cancer	0.000175	0.000597	CcSEcCtD
Phenytoin—Nausea—Mitoxantrone—lymphatic system cancer	0.000174	0.000593	CcSEcCtD
Phenytoin—Back pain—Methotrexate—lymphatic system cancer	0.000173	0.00059	CcSEcCtD
Phenytoin—Ill-defined disorder—Methotrexate—lymphatic system cancer	0.000166	0.000566	CcSEcCtD
Phenytoin—Anaemia—Methotrexate—lymphatic system cancer	0.000165	0.000563	CcSEcCtD
Phenytoin—Malaise—Methotrexate—lymphatic system cancer	0.000161	0.00055	CcSEcCtD
Phenytoin—Vertigo—Methotrexate—lymphatic system cancer	0.000161	0.000548	CcSEcCtD
Phenytoin—Leukopenia—Methotrexate—lymphatic system cancer	0.00016	0.000546	CcSEcCtD
Phenytoin—Cough—Methotrexate—lymphatic system cancer	0.000156	0.000532	CcSEcCtD
Phenytoin—Convulsion—Methotrexate—lymphatic system cancer	0.000155	0.000528	CcSEcCtD
Phenytoin—Arthralgia—Methotrexate—lymphatic system cancer	0.000152	0.000519	CcSEcCtD
Phenytoin—Chest pain—Methotrexate—lymphatic system cancer	0.000152	0.000519	CcSEcCtD
Phenytoin—Myalgia—Methotrexate—lymphatic system cancer	0.000152	0.000519	CcSEcCtD
Phenytoin—Discomfort—Methotrexate—lymphatic system cancer	0.00015	0.000513	CcSEcCtD
Phenytoin—Confusional state—Methotrexate—lymphatic system cancer	0.000147	0.000502	CcSEcCtD
Phenytoin—Anaphylactic shock—Methotrexate—lymphatic system cancer	0.000146	0.000497	CcSEcCtD
Phenytoin—Infection—Methotrexate—lymphatic system cancer	0.000145	0.000494	CcSEcCtD
Phenytoin—Nervous system disorder—Methotrexate—lymphatic system cancer	0.000143	0.000488	CcSEcCtD
Phenytoin—Thrombocytopenia—Methotrexate—lymphatic system cancer	0.000143	0.000487	CcSEcCtD
Phenytoin—Hyperhidrosis—Methotrexate—lymphatic system cancer	0.000141	0.000481	CcSEcCtD
Phenytoin—Anorexia—Methotrexate—lymphatic system cancer	0.000139	0.000474	CcSEcCtD
Phenytoin—Hypotension—Methotrexate—lymphatic system cancer	0.000136	0.000465	CcSEcCtD
Phenytoin—Musculoskeletal discomfort—Methotrexate—lymphatic system cancer	0.000133	0.000453	CcSEcCtD
Phenytoin—Insomnia—Methotrexate—lymphatic system cancer	0.000132	0.00045	CcSEcCtD
Phenytoin—Paraesthesia—Methotrexate—lymphatic system cancer	0.000131	0.000447	CcSEcCtD
Phenytoin—Dyspnoea—Methotrexate—lymphatic system cancer	0.00013	0.000444	CcSEcCtD
Phenytoin—Somnolence—Methotrexate—lymphatic system cancer	0.00013	0.000442	CcSEcCtD
Phenytoin—Dyspepsia—Methotrexate—lymphatic system cancer	0.000128	0.000438	CcSEcCtD
Phenytoin—Decreased appetite—Methotrexate—lymphatic system cancer	0.000127	0.000432	CcSEcCtD
Phenytoin—Gastrointestinal disorder—Methotrexate—lymphatic system cancer	0.000126	0.000429	CcSEcCtD
Phenytoin—Fatigue—Methotrexate—lymphatic system cancer	0.000126	0.000429	CcSEcCtD
Phenytoin—Feeling abnormal—Methotrexate—lymphatic system cancer	0.00012	0.00041	CcSEcCtD
Phenytoin—Urticaria—Methotrexate—lymphatic system cancer	0.000116	0.000395	CcSEcCtD
Phenytoin—Body temperature increased—Methotrexate—lymphatic system cancer	0.000115	0.000393	CcSEcCtD
Phenytoin—Hypersensitivity—Methotrexate—lymphatic system cancer	0.000108	0.000367	CcSEcCtD
Phenytoin—Asthenia—Methotrexate—lymphatic system cancer	0.000105	0.000357	CcSEcCtD
Phenytoin—Pruritus—Methotrexate—lymphatic system cancer	0.000103	0.000352	CcSEcCtD
Phenytoin—Diarrhoea—Methotrexate—lymphatic system cancer	9.99e-05	0.00034	CcSEcCtD
Phenytoin—Dizziness—Methotrexate—lymphatic system cancer	9.65e-05	0.000329	CcSEcCtD
Phenytoin—Vomiting—Methotrexate—lymphatic system cancer	9.28e-05	0.000316	CcSEcCtD
Phenytoin—Rash—Methotrexate—lymphatic system cancer	9.2e-05	0.000314	CcSEcCtD
Phenytoin—Dermatitis—Methotrexate—lymphatic system cancer	9.2e-05	0.000313	CcSEcCtD
Phenytoin—Headache—Methotrexate—lymphatic system cancer	9.15e-05	0.000312	CcSEcCtD
Phenytoin—Nausea—Methotrexate—lymphatic system cancer	8.67e-05	0.000296	CcSEcCtD
